Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2630581000168114 | Auralgan (benzocaine 14 mg / 1 mL + phenazone 54 mg / 1 mL) ear drops, 15 mL (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2630591000168112 | Auralgan ear drops, 15 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Auralgan ear drops, 15 mL | Is a | trade product pack | true | Inferred relationship | Some | ||
| Auralgan ear drops, 15 mL | Is a | phenazone 5.4% + benzocaine 1.4% ear drops, 15 mL | true | Inferred relationship | Some | ||
| Auralgan ear drops, 15 mL | has TPUU | Auralgan ear drops | true | Inferred relationship | Some | 1 | |
| Auralgan ear drops, 15 mL | has TP | Auralgan | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Auralgan ear drops, 15 mL, bottle | Is a | True | Auralgan ear drops, 15 mL | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR